RecruitingNot ApplicableNCT06752928

A Study Comparing Dexcom Continuous Glucose Monitoring to Point of Care Glucose Testing for the Management of Hospital and Post-Discharge Subjects With Type 1 Diabetes

A Randomized Controlled Trial Comparing Dexcom Continuous Glucose Monitoring to Point of Care Glucose Testing for the Management of Hospital and Post-Discharge Subjects With Type 1 Diabetes


Sponsor

Emory University

Enrollment

100 participants

Start Date

May 12, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to compare inpatient glycemic control by measuring the percentage of time in the range of 70-180 mg/dl and the frequency of hypoglycemia between Dexcom G7 Continuous Glucose Monitoring (CGM) and Point of Care (POC) Blood Glucose Testing in poorly controlled subjects with Type 1 Diabetes Mellitus. The main question it aims to answer is: -Whether there is a difference between POC testing (standard of care) and Real-time CGM in glycemic control and hypoglycemic events during hospitalization:


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study compares continuous glucose monitoring (a sensor worn on the skin that tracks blood sugar around the clock) to standard fingerstick blood sugar checks in hospitalized patients with Type 1 diabetes who have poorly controlled blood sugar. **You may be eligible if...** - You have Type 1 diabetes treated with insulin - You were admitted to the hospital with dangerously high blood sugar (including diabetic ketoacidosis) - Your expected hospital stay is more than 3 days **You may NOT be eligible if...** - You are being treated in the ICU - You were already using a continuous glucose monitor before admission - You have Type 2 diabetes - You are on systemic immunosuppressants or have cystic fibrosis - You need an MRI during your hospital stay - You are pregnant or breastfeeding - You have end-stage kidney disease (eGFR below 30) or severe liver disease - You are a prisoner Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEDexcom G7 rtCGM

The Dexcom G7 Continuous Glucose Monitoring System (Dexcom G7 CGM System or G7) is a glucose monitoring system that continuously measures glucose in the interstitial fluid. It aids in the detection of episodes of hyperglycemia and hypoglycemia, facilitating both acute and long-term therapy adjustments

DIAGNOSTIC_TESTCapillary Blood glucose Testing (POC)

POC glucose meters measure whole blood and convert the results to plasma glucose concentrations, which is the standardized form used in clinical practice.


Locations(1)

Grady Memorial Hospital

Atlanta, Georgia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06752928


Related Trials